Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Unlock the discovery of antibodies to this difficult target class
GPCRs are hard to drug. However, Twist produces synthetic mAb libraries for focus on effective sequence space and simultaneous screening against multiple targets. Twist Biopharma can develop over 100,000 different GPCR binding motifs to generate new leads against any GPCR of interest.
© 2025 Twist Bioscience. All rights reserved.